サマリー

ヒト用ワクチンの世界市場 2024-2028
ヒト用ワクチン市場は2023〜2028年に291億米ドル成長し、予測期間中のCAGRは9.49%で加速すると予測される。この調査レポートは、ヒト用ワクチン市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析を掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、小児人口の増加、慢性感染症に対する新規ワクチンのニーズ、政府による公的予防接種プログラムなどが牽引しています。
Technavio社のヒト用ワクチン市場は以下のように分類されます：
投与経路別
- 筋肉内
- 皮下
- 経口
エンドユーザー別
- 小児科
- 成人
地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域（ROW）
本調査では、新規ワクチンの研究開発が、今後数年間のヒト用ワクチン市場の成長を促進する主な要因の1つであるとしている。また、ワクチン送達システムの進歩やナノ粒子ワクチンの開発は、市場の大きな需要につながるでしょう。
本レポートでは、ヒト用ワクチン市場について以下の領域をカバーしています：
- ヒト用ワクチンの市場規模
- ヒト用ワクチン市場予測
- ヒト用ワクチン市場の産業分析
本レポートでは、アステラス製薬、AstraZeneca Plc、Bavarian Nordic AS、Bharat Biotech Ltd.、BioNTech SE、CanSino Biologics Inc.、CSL Ltd.、第一三共、Emergent BioSolutions Ltd.など、ヒトワクチン市場の主要ベンダーの詳細な分析を掲載しています。Ltd.、Emergent BioSolutions Inc.、GlaxoSmithKline Plc.、Gradalis Inc.、Inovio Pharmaceuticals Inc.、Johnson and Johnson、Merck and Co.Inc.、Mitsubishi Chemical Group Corp.、Moderna Inc.、Novavax Inc.、Pfizer Inc.、Serum Institute of India Pvt.Ltd.、Sanofi SA。また、ヒトワクチン市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/human-vaccine-market-industry-analysis をご覧ください。
当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
o Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global human vaccine market 2018 - 2022
o Exhibit 18: Historic Market Size - Data Table on global human vaccine market 2018 - 2022 ($ billion)
o 4.2 Route of Administration Segment Analysis 2018 - 2022
o Exhibit 19: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ billion)
o 4.3 End-user Segment Analysis 2018 - 2022
o Exhibit 20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
o 4.4 Geography Segment Analysis 2018 - 2022
o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
o 4.5 Country Segment Analysis 2018 - 2022
o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
• 6 Market Segmentation by Route of Administration
o 6.1 Market segments
o Exhibit 30: Chart on Route of Administration - Market share 2023-2028 (%)
o Exhibit 31: Data Table on Route of Administration - Market share 2023-2028 (%)
o 6.2 Comparison by Route of Administration
o Exhibit 32: Chart on Comparison by Route of Administration
o Exhibit 33: Data Table on Comparison by Route of Administration
o 6.3 Intramuscular - Market size and forecast 2023-2028
o Exhibit 34: Chart on Intramuscular - Market size and forecast 2023-2028 ($ billion)
o Exhibit 35: Data Table on Intramuscular - Market size and forecast 2023-2028 ($ billion)
o Exhibit 36: Chart on Intramuscular - Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Intramuscular - Year-over-year growth 2023-2028 (%)
o 6.4 Subcutaneous - Market size and forecast 2023-2028
o Exhibit 38: Chart on Subcutaneous - Market size and forecast 2023-2028 ($ billion)
o Exhibit 39: Data Table on Subcutaneous - Market size and forecast 2023-2028 ($ billion)
o Exhibit 40: Chart on Subcutaneous - Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on Subcutaneous - Year-over-year growth 2023-2028 (%)
o 6.5 Oral - Market size and forecast 2023-2028
o Exhibit 42: Chart on Oral - Market size and forecast 2023-2028 ($ billion)
o Exhibit 43: Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
o Exhibit 44: Chart on Oral - Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on Oral - Year-over-year growth 2023-2028 (%)
o 6.6 Market opportunity by Route of Administration
o Exhibit 46: Market opportunity by Route of Administration ($ billion)
o Exhibit 47: Data Table on Market opportunity by Route of Administration ($ billion)
• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 48: Chart on End-user - Market share 2023-2028 (%)
o Exhibit 49: Data Table on End-user - Market share 2023-2028 (%)
o 7.2 Comparison by End-user
o Exhibit 50: Chart on Comparison by End-user
o Exhibit 51: Data Table on Comparison by End-user
o 7.3 Pediatrics - Market size and forecast 2023-2028
o Exhibit 52: Chart on Pediatrics - Market size and forecast 2023-2028 ($ billion)
o Exhibit 53: Data Table on Pediatrics - Market size and forecast 2023-2028 ($ billion)
o Exhibit 54: Chart on Pediatrics - Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Pediatrics - Year-over-year growth 2023-2028 (%)
o 7.4 Adults - Market size and forecast 2023-2028
o Exhibit 56: Chart on Adults - Market size and forecast 2023-2028 ($ billion)
o Exhibit 57: Data Table on Adults - Market size and forecast 2023-2028 ($ billion)
o Exhibit 58: Chart on Adults - Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Adults - Year-over-year growth 2023-2028 (%)
o 7.5 Market opportunity by End-user
o Exhibit 60: Market opportunity by End-user ($ billion)
o Exhibit 61: Data Table on Market opportunity by End-user ($ billion)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 65: Chart on Geographic comparison
o Exhibit 66: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2023-2028
o Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
o Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
o Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
o 9.4 Europe - Market size and forecast 2023-2028
o Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
o Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
o 9.5 Asia - Market size and forecast 2023-2028
o Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
o Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
o Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
o Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
o 9.7 US - Market size and forecast 2023-2028
o Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
o Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
o 9.8 Germany - Market size and forecast 2023-2028
o Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
o Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
o 9.9 China - Market size and forecast 2023-2028
o Exhibit 91: Chart on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 92: Data Table on China - Market size and forecast 2023-2028 ($ billion)
o Exhibit 93: Chart on China - Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on China - Year-over-year growth 2023-2028 (%)
o 9.10 UK - Market size and forecast 2023-2028
o Exhibit 95: Chart on UK - Market size and forecast 2023-2028 ($ billion)
o Exhibit 96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
o Exhibit 97: Chart on UK - Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on UK - Year-over-year growth 2023-2028 (%)
o 9.11 Canada - Market size and forecast 2023-2028
o Exhibit 99: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
o Exhibit 100: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
o Exhibit 101: Chart on Canada - Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 103: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 105: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 107: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 108: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 109: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 110: Matrix on vendor position and classification
o 12.3 Astellas Pharma Inc.
o Exhibit 111: Astellas Pharma Inc. - Overview
o Exhibit 112: Astellas Pharma Inc. - Product / Service
o Exhibit 113: Astellas Pharma Inc. - Key news
o Exhibit 114: Astellas Pharma Inc. - Key offerings
o 12.4 AstraZeneca Plc
o Exhibit 115: AstraZeneca Plc - Overview
o Exhibit 116: AstraZeneca Plc - Product / Service
o Exhibit 117: AstraZeneca Plc - Key news
o Exhibit 118: AstraZeneca Plc - Key offerings
o 12.5 Bavarian Nordic AS
o Exhibit 119: Bavarian Nordic AS - Overview
o Exhibit 120: Bavarian Nordic AS - Product / Service
o Exhibit 121: Bavarian Nordic AS - Key offerings
o 12.6 Bharat Biotech Ltd.
o Exhibit 122: Bharat Biotech Ltd. - Overview
o Exhibit 123: Bharat Biotech Ltd. - Product / Service
o Exhibit 124: Bharat Biotech Ltd. - Key news
o Exhibit 125: Bharat Biotech Ltd. - Key offerings
o 12.7 CSL Ltd.
o Exhibit 126: CSL Ltd. - Overview
o Exhibit 127: CSL Ltd. - Business segments
o Exhibit 128: CSL Ltd. - Key offerings
o Exhibit 129: CSL Ltd. - Segment focus
o 12.8 Daiichi Sankyo Co. Ltd.
o Exhibit 130: Daiichi Sankyo Co. Ltd. - Overview
o Exhibit 131: Daiichi Sankyo Co. Ltd. - Product / Service
o Exhibit 132: Daiichi Sankyo Co. Ltd. - Key news
o Exhibit 133: Daiichi Sankyo Co. Ltd. - Key offerings
o 12.9 Emergent BioSolutions Inc.
o Exhibit 134: Emergent BioSolutions Inc. - Overview
o Exhibit 135: Emergent BioSolutions Inc. - Product / Service
o Exhibit 136: Emergent BioSolutions Inc. - Key news
o Exhibit 137: Emergent BioSolutions Inc. - Key offerings
o 12.10 GlaxoSmithKline Plc
o Exhibit 138: GlaxoSmithKline Plc - Overview
o Exhibit 139: GlaxoSmithKline Plc - Business segments
o Exhibit 140: GlaxoSmithKline Plc - Key news
o Exhibit 141: GlaxoSmithKline Plc - Key offerings
o Exhibit 142: GlaxoSmithKline Plc - Segment focus
o 12.11 Inovio Pharmaceuticals Inc.
o Exhibit 143: Inovio Pharmaceuticals Inc. - Overview
o Exhibit 144: Inovio Pharmaceuticals Inc. - Product / Service
o Exhibit 145: Inovio Pharmaceuticals Inc. - Key news
o Exhibit 146: Inovio Pharmaceuticals Inc. - Key offerings
o 12.12 Merck and Co. Inc.
o Exhibit 147: Merck and Co. Inc. - Overview
o Exhibit 148: Merck and Co. Inc. - Business segments
o Exhibit 149: Merck and Co. Inc. - Key news
o Exhibit 150: Merck and Co. Inc. - Key offerings
o Exhibit 151: Merck and Co. Inc. - Segment focus
o 12.13 Mitsubishi Chemical Group Corp.
o Exhibit 152: Mitsubishi Chemical Group Corp. - Overview
o Exhibit 153: Mitsubishi Chemical Group Corp. - Business segments
o Exhibit 154: Mitsubishi Chemical Group Corp. - Key offerings
o Exhibit 155: Mitsubishi Chemical Group Corp. - Segment focus
o 12.14 Moderna Inc.
o Exhibit 156: Moderna Inc. - Overview
o Exhibit 157: Moderna Inc. - Product / Service
o Exhibit 158: Moderna Inc. - Key offerings
o 12.15 Pfizer Inc.
o Exhibit 159: Pfizer Inc. - Overview
o Exhibit 160: Pfizer Inc. - Product / Service
o Exhibit 161: Pfizer Inc. - Key news
o Exhibit 162: Pfizer Inc. - Key offerings
o 12.16 Sanofi SA
o Exhibit 163: Sanofi SA - Overview
o Exhibit 164: Sanofi SA - Business segments
o Exhibit 165: Sanofi SA - Key news
o Exhibit 166: Sanofi SA - Key offerings
o Exhibit 167: Sanofi SA - Segment focus
o 12.17 Serum Institute of India Pvt. Ltd.
o Exhibit 168: Serum Institute of India Pvt. Ltd. - Overview
o Exhibit 169: Serum Institute of India Pvt. Ltd. - Product / Service
o Exhibit 170: Serum Institute of India Pvt. Ltd. - Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 171: Inclusions checklist
o Exhibit 172: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 173: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 174: Research methodology
o Exhibit 175: Validation techniques employed for market sizing
o Exhibit 176: Information sources
o 13.5 List of abbreviations
o Exhibit 177: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global human vaccine market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibits31: Data Table on Route of Administration - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Route of Administration
Exhibits33: Data Table on Comparison by Route of Administration
Exhibits34: Chart on Intramuscular - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Intramuscular - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Intramuscular - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Intramuscular - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Subcutaneous - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Subcutaneous - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Subcutaneous - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Subcutaneous - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Oral - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by Route of Administration ($ billion)
Exhibits47: Data Table on Market opportunity by Route of Administration ($ billion)
Exhibits48: Chart on End-user - Market share 2023-2028 (%)
Exhibits49: Data Table on End-user - Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by End-user
Exhibits51: Data Table on Comparison by End-user
Exhibits52: Chart on Pediatrics - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Pediatrics - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Pediatrics - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Pediatrics - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Adults - Market size and forecast 2023-2028 ($ billion)
Exhibits57: Data Table on Adults - Market size and forecast 2023-2028 ($ billion)
Exhibits58: Chart on Adults - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Adults - Year-over-year growth 2023-2028 (%)
Exhibits60: Market opportunity by End-user ($ billion)
Exhibits61: Data Table on Market opportunity by End-user ($ billion)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ billion)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits105: Impact of drivers and challenges in 2023 and 2028
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: Astellas Pharma Inc. - Overview
Exhibits112: Astellas Pharma Inc. - Product / Service
Exhibits113: Astellas Pharma Inc. - Key news
Exhibits114: Astellas Pharma Inc. - Key offerings
Exhibits115: AstraZeneca Plc - Overview
Exhibits116: AstraZeneca Plc - Product / Service
Exhibits117: AstraZeneca Plc - Key news
Exhibits118: AstraZeneca Plc - Key offerings
Exhibits119: Bavarian Nordic AS - Overview
Exhibits120: Bavarian Nordic AS - Product / Service
Exhibits121: Bavarian Nordic AS - Key offerings
Exhibits122: Bharat Biotech Ltd. - Overview
Exhibits123: Bharat Biotech Ltd. - Product / Service
Exhibits124: Bharat Biotech Ltd. - Key news
Exhibits125: Bharat Biotech Ltd. - Key offerings
Exhibits126: CSL Ltd. - Overview
Exhibits127: CSL Ltd. - Business segments
Exhibits128: CSL Ltd. - Key offerings
Exhibits129: CSL Ltd. - Segment focus
Exhibits130: Daiichi Sankyo Co. Ltd. - Overview
Exhibits131: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibits132: Daiichi Sankyo Co. Ltd. - Key news
Exhibits133: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits134: Emergent BioSolutions Inc. - Overview
Exhibits135: Emergent BioSolutions Inc. - Product / Service
Exhibits136: Emergent BioSolutions Inc. - Key news
Exhibits137: Emergent BioSolutions Inc. - Key offerings
Exhibits138: GlaxoSmithKline Plc - Overview
Exhibits139: GlaxoSmithKline Plc - Business segments
Exhibits140: GlaxoSmithKline Plc - Key news
Exhibits141: GlaxoSmithKline Plc - Key offerings
Exhibits142: GlaxoSmithKline Plc - Segment focus
Exhibits143: Inovio Pharmaceuticals Inc. - Overview
Exhibits144: Inovio Pharmaceuticals Inc. - Product / Service
Exhibits145: Inovio Pharmaceuticals Inc. - Key news
Exhibits146: Inovio Pharmaceuticals Inc. - Key offerings
Exhibits147: Merck and Co. Inc. - Overview
Exhibits148: Merck and Co. Inc. - Business segments
Exhibits149: Merck and Co. Inc. - Key news
Exhibits150: Merck and Co. Inc. - Key offerings
Exhibits151: Merck and Co. Inc. - Segment focus
Exhibits152: Mitsubishi Chemical Group Corp. - Overview
Exhibits153: Mitsubishi Chemical Group Corp. - Business segments
Exhibits154: Mitsubishi Chemical Group Corp. - Key offerings
Exhibits155: Mitsubishi Chemical Group Corp. - Segment focus
Exhibits156: Moderna Inc. - Overview
Exhibits157: Moderna Inc. - Product / Service
Exhibits158: Moderna Inc. - Key offerings
Exhibits159: Pfizer Inc. - Overview
Exhibits160: Pfizer Inc. - Product / Service
Exhibits161: Pfizer Inc. - Key news
Exhibits162: Pfizer Inc. - Key offerings
Exhibits163: Sanofi SA - Overview
Exhibits164: Sanofi SA - Business segments
Exhibits165: Sanofi SA - Key news
Exhibits166: Sanofi SA - Key offerings
Exhibits167: Sanofi SA - Segment focus
Exhibits168: Serum Institute of India Pvt. Ltd. - Overview
Exhibits169: Serum Institute of India Pvt. Ltd. - Product / Service
Exhibits170: Serum Institute of India Pvt. Ltd. - Key offerings
Exhibits171: Inclusions checklist
Exhibits172: Exclusions checklist
Exhibits173: Currency conversion rates for US$
Exhibits174: Research methodology
Exhibits175: Validation techniques employed for market sizing
Exhibits176: Information sources
Exhibits177: List of abbreviations